United Therapeutics UTHR
NASDAQ UTHR
$541.70 -29.68 (-5.19%)
At close: Oct 2, 2026 · 4:00 PM EDT

United Therapeutics (UTHR) Interest & Investment Income (2009 - 2026)

Updated

United Therapeutics (UTHR) recorded Interest & Investment Income of $31.5 million in Q2 2026, down 38.6% from $51.3 million a year earlier and down 24.6% from the prior quarter.

Analysis

United Therapeutics (UTHR) Interest & Investment Income (2009 - 2026) Analysis & Trends

On a TTM basis, United Therapeutics' Interest & Investment Income came in at $162.9 million as of Jun 30, 2026, down 19.2% year-over-year; for FY2025, it came in at $192 million, down 3.6% from FY2024.

  • Annual Interest & Investment Income has a five-year compound annual growth rate of 46.3% (FY2020 to FY2025).
  • Across earlier years, Interest & Investment Income came in at $199.1 million in FY2024 (+22.4%), $162.7 million in FY2023 (+260.0%), $45.2 million in FY2022 (+170.7%) and $16.7 million in FY2021 (-41.6%).
  • The Q2 2026 figure is the lowest quarterly Interest & Investment Income since Q1 2023.
  • On a year-over-year basis, Interest & Investment Income has declined for four consecutive quarters, with an average decline of 7.9% over the last eight quarters.
  • Peak year-over-year performance for Interest & Investment Income in the last five years was growth of 579.1% in Q1 2023, against a decline of 40.6% in Q3 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at $41.8 million (Q1 2026), $43.2 million (Q4 2025) and $46.4 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 United Therapeutics 23.12 Bn 12.61 Bn 683.80 Mn 31.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 31.50 Mn
Mar 31, 2026 41.80 Mn
Dec 31, 2025 43.20 Mn
Sep 30, 2025 46.40 Mn
Jun 30, 2025 51.30 Mn
Mar 31, 2025 51.10 Mn
Dec 31, 2024 49.30 Mn
Sep 30, 2024 49.80 Mn
Jun 30, 2024 46.20 Mn
Mar 31, 2024 53.80 Mn
Dec 31, 2023 51.00 Mn
Sep 30, 2023 45.30 Mn
Jun 30, 2023 37.20 Mn
Mar 31, 2023 29.20 Mn
Dec 31, 2022 20.80 Mn
Sep 30, 2022 13.30 Mn
Jun 30, 2022 6.80 Mn
Mar 31, 2022 4.30 Mn
Dec 31, 2021 4.20 Mn
Sep 30, 2021 3.80 Mn
API Access

United Therapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=UTHR&period=max&api_key=YOUR_API_KEY